Skip to content

Final study results show telaprevir is safe and effective for HIV/HCV co-infected people

Mark Sulkowski from Johns Hopkins University School of Medicine.  © Liz Highleyman / hivandhepatitis.com

New hepatitis C drugs danoprevir and mericitabine are safe and effective for prior non-responders and people with cirrhosis

New cohort shows the impact of hepatitis B and hepatitis C on the 'baby boom' generation

Recreational drug use associated with non-prescription use of HIV PrEP among gay men in Australia

Some sexual lubricants damage cells – but may not increase HIV risk

Only half of people on HIV treatment fit 'Swiss Statement' criteria for non-infectiousness in US study

Sexual preference is a better guide to HIV risk in gay men than reported behaviour, Chinese study suggests

Young gay men with HIV in the UK worry about disclosure, transmission and prosecution – older ones about confidence and sex

Very high HIV incidence among men who have sex with men in Kenya